Skip to content
Insider tapeFilings through Fri, Oct 9
Watchlist

John P. Hamill

CFO at Aprea Therapeutics, Inc. (APRE)

Purchase track record

Not enough history. Based on 0 purchases with a full 90 days of price history.

—
Avg. 90-day return—
vs. S&P 500—
Beat the market—
Paper profit on buys−$4K
Total bought / sold$11K / $0

Reported trades

Filed Stock Type Shares Price Value Since
Feb 2SEC APREAprea Therapeutics, Inc. Buy 5,70033,433 held (+21%) $0.89 $5K -32.1%
Dec 11SEC APREAprea Therapeutics, Inc. Buy 5,00027,733 held (+22%) $1.17 $6K -48.4%
  • Buy

    CFO John P. Hamill bought $5K of APRE at $0.89 — raises the stake by 21%.

  • Buy

    CFO John P. Hamill bought $6K of APRE at $1.17 — first open-market purchase in our records; raises the stake by 22%.